絞り込み

16379

広告

「abatacept」の検索結果

3070件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review.

Murine LRBA-deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.

Abatacept: A Review in Rheumatoid Arthritis.

Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.

Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.

Tregs restrain dendritic cell autophagy to ameliorate autoimmunity.

Targeting the programmed cell death-1 pathway in rheumatoid arthritis.

The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.

Abatacept attenuates T follicular helper-cell-dependent B-cell hyperactivity in primary Sjögren's syndrome.

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.

Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Whipple's disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure.

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.

Spondyloarthropathies: Abatacept treatment for PsA.

Challenges and Opportunities in Targeting the CD28/CTLA-4 Pathway in Transplantation and Autoimmunity.

Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.

Interleukin-10-producing LAG3(+) regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります